Shares of CryoPort Inc (NASDAQ:CYRX) have received an average recommendation of “Buy” from the six ratings firms that are covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation, four have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $19.75.

A number of analysts have commented on CYRX shares. ValuEngine lowered shares of CryoPort from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, January 15th. BidaskClub raised shares of CryoPort from a “buy” rating to a “strong-buy” rating in a research report on Friday, February 15th.

NASDAQ CYRX traded up $0.09 on Friday, reaching $11.65. The company’s stock had a trading volume of 132,177 shares, compared to its average volume of 191,176. CryoPort has a twelve month low of $6.66 and a twelve month high of $16.88. The company has a market capitalization of $351.11 million, a price-to-earnings ratio of -37.58 and a beta of 1.09.

CryoPort (NASDAQ:CYRX) last issued its quarterly earnings results on Thursday, March 7th. The consumer goods maker reported ($0.08) earnings per share for the quarter, meeting the Zacks’ consensus estimate of ($0.08). CryoPort had a negative net margin of 48.69% and a negative return on equity of 37.77%. The company had revenue of $5.69 million during the quarter, compared to the consensus estimate of $5.62 million. On average, sell-side analysts anticipate that CryoPort will post -0.28 EPS for the current year.

Several hedge funds and other institutional investors have recently bought and sold shares of CYRX. Metropolitan Life Insurance Co. NY grew its holdings in CryoPort by 356.6% during the fourth quarter. Metropolitan Life Insurance Co. NY now owns 8,607 shares of the consumer goods maker’s stock valued at $95,000 after purchasing an additional 6,722 shares during the last quarter. FNY Investment Advisers LLC bought a new stake in CryoPort in the 3rd quarter valued at approximately $147,000. HRT Financial LLC bought a new stake in CryoPort in the 3rd quarter valued at approximately $156,000. MML Investors Services LLC bought a new stake in CryoPort in the 4th quarter valued at approximately $157,000. Finally, Bank of America Corp DE lifted its stake in CryoPort by 92.3% in the 4th quarter. Bank of America Corp DE now owns 16,037 shares of the consumer goods maker’s stock valued at $176,000 after acquiring an additional 7,697 shares in the last quarter. 48.31% of the stock is owned by institutional investors and hedge funds.

CryoPort Company Profile

Cryoport, Inc provides cryogenic logistics solutions to the life sciences industry in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, a dry vapor cryogenic shipper that use liquid nitrogen contained inside a vacuum insulated vessel, which serves as a refrigerant to provide stable storage temperatures.

See Also: What is the Coverage Ratio?

Receive News & Ratings for CryoPort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort and related companies with MarketBeat.com's FREE daily email newsletter.